Differential Control of Neonatal Tolerance by Antigen Dose versus Extended Exposure and Adjuvant

This publication has 26 references indexed in Scilit:

• Neonatal Exposure to a Self-Peptide–Immunoglobulin Chimera Circumvents the Use of Adjuvant and Confers Resistance to Autoimmune Disease by a Novel Mechanism Involving Interleukin 4 Lymph Node Deviation and Interferon γ–mediated Splenic Anergy
  The Journal of Experimental Medicine, 1998
• Presentation of a T Cell Receptor Antagonist Peptide by Immunoglobulins Ablates Activation of T Cells by a Synthetic Peptide or Proteins Requiring Endocytic Processing
  The Journal of Experimental Medicine, 1997
• Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System
  Cell, 1996
• Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity.
  The Journal of Experimental Medicine, 1996
• Induction of T _H 1 and T _H 2 Immunity in Neonatal Mice
  Science, 1996
• Induction of Protective CTL Responses in Newborn Mice by a Murine Retrovirus
  Science, 1996
• Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells
  Science, 1996
• Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice.
  The Journal of Experimental Medicine, 1996
• ENHANCED TYPE 2 AND DIMINISHED TYPE 1 CYTOKINES IN NEONATAL TOLERANCE
  Transplantation, 1995
• Immunological Aspects of Demyelinating Diseases
  Annual Review of Immunology, 1992